Cationic lipids and polymers mediated vectors for delivery of siRNA

Journal of Controlled Release

Volumn 123, Issue 1, 2007, Pages 1-10

  Zhang, Shubiao ^a   Zhao, Budiao ^a   Jiang, Huiming ^a   Wang, Bing ^a   Ma, Baichao ^a  

^a DALIAN NATIONALITIES UNIVERSITY   (China)

Author keywords

Cationic lipids; Cationic liposomes; Polymer nanoparticles; RNAi; siRNA

Indexed keywords

CATIONIC LIPIDS; CATIONIC LIPOSOMES; NON-VIRAL VECTORS; POLYMER NANOPARTICLES;

BIOPOLYMERS; DISEASES; LIPIDS; NANOPARTICLES; TRANSCRIPTION; VIRUSES;

RNA;

2 (3 [BIS (3 AMINOPROPYL)AMINO]PROPYLAMINO) N DITETRADECYLCARBAMOYLMETHYLACETAMIDE; CATION; CHITOSAN; DIOLEOYLPHOSPHATIDYLCHOLINE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; DIPALMITOYLPHOSPHATIDYLGLYCEROL; INTERLEUKIN 12P40; LAURIC ACID; LIPID; LIPOFECTAMINE; LIPOFECTAMINE 2000; LIPOFECTINE; LIPOSOME; LITHOCHOLIC ACID; MACROGOL; MACROGOL 2000; N 1 CHOLESTERYLOXYCARBONYL 3,7 DIAZONANE 1,9 DIAMINE; N [1 (2,3 DIOLEOYLOXY)PROPYL] N,N,N TRIMETHYLAMMONIUM CHLORIDE; N [1 (2,3 DIOLEYLOXY)PROPYL] N,N,N TRIMETHYLAMMONIUM CHLORIDE; NANOPARTICLE; OLIGOFECTAMINE; POLY(4 VINYLPYRIDINE); POLYETHYLENEIMINE; POLYLYSINE; POLYMER; RPR 209120; SMALL INTERFERING RNA; UBC13; UNCLASSIFIED DRUG; UNINDEXED DRUG;

DRUG FORMULATION; DRUG RELEASE; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; MEDICAL LITERATURE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; RNA INTERFERENCE; TRANSPOSON;

ANIMALS; CATIONS; GENE TARGETING; GENETIC VECTORS; HUMANS; LIPIDS; POLYMERS; RNA, SMALL INTERFERING;

EID: 34548818764     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2007.07.016     Document Type: Review

References (109)

1. Montgomery M.K., Xu S., and Fire A. RNA as a target of double stranded RNA-mediated genetic interference in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15502-15507
2. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
3. Guo S., and Kemphues K.J. par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell 81 (1995) 611-620
4. Cheng J.C., Moore T.B., and Sakamoto K.M. RNA interference and human disease. Mol. Genet. Metab. 80 (2003) 121-128
5. Jana S., Chakraborty C., Nandi S., and Deb J.K. RNA interference: potential therapeutic targets. Appl. Microbiol. Biotechnol. 65 (2004) 649-657
6. Dillon C.P., Sandy P., Nencioni A., Kissler S., Rubinson D.A., and Van Parijs L. RNAi as an experimental and therapeutic tool to study and regulate physiological and disease processes. Annu. Rev. Physiol. 67 (2005) 147-173
7. Dykxhoorn D.M., Novina C.D., and Sharp P.A. Killing the messenger: short RNAs that silence gene expression. Nat. Rev., Mol. Cell Biol. 4 (2003) 457-467
8. Leung P.K., and Whittaker P.A. RNA interference: from gene silencing to gene-specific therapeutics. Pharmacol. Ther. 107 (2005) 222-239
9. Li C.X., Parker A., Menocal E., Xiang S., Borodyansky L., and Fruehauf J.H. Delivery of RNA Interference. Cell Cycle 5 (2006) 2103-2109
10. Farhood H., Bottega R., Epand R.M., and Huang L. Effect of cationic cholesterol derivatives on gene transfer and protein kinase C activity. Biochim. Biophys. Acta 1111 (1992) 239-246
11. Romoren K., Thu B.J., Bols N.C., and Evensen O. Transfection efficiency and cytotoxicity of cationic liposomes in salmonid cell lines of hepatocyte and macrophage origin. Biochim. Biophys. Acta 1663 (2004) 127-134
12. Scales C.W., Huang F., Li N., Vasilieva Y.A., Ray J., Convertine A.J., and McCormick C.L. Corona-stabilized interpolyelectrolyte complexes of siRNA with nonimmunogenic, hydrophilic/cationic block copolymers prepared by aqueous RAFT polymerization. Macromolecules 39 (2006) 6871-6881
13. Napoli C., Lemieux C., and Jorgensen R. Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell 2 (1990) 279-289
14. Ketzinel-Gilad M., Shaul Y., and Galun E. RNA interference for antiviral therapy. J. Gene Med. 8 (2006) 933-950
15. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., Horvitz H.R., and Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403 (2000) 901-906
16. Ahlquist P. RNA-dependent RNA polymerases, viruses, and RNA silencing. Science 296 (2002) 1270-1273
17. Tabara H., Sarkissian M., Kelly W.G., Fleenor J., Grishok A., Timmons L., Fire A., and Mello C.C. The rde-1 gene, RNA interference, and transposon silencing in C. elegans. Cell 99 (1999) 123-132
18. Rubinson D.A., Dillon C.P., Kwiatkowski A.V., Sievers C., Yang L., Kopinja J., Rooney D.L., Ihriq M.M., McManus M.T., Gertler F.B., Scott M.L., and Van Parijs L. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33 (2003) 401-406
19. Ui-Tei K., Zenno S., Miyata Y., and Saigo K. Sensitive assay of RNA interfernce in Drosophila and Chinese hamster cultured cells using firefly luciferase gene as target. FEBS Lett. 479 (2000) 79-82
20. Wianny F., and Zernicka-Goetz M. Specific interference with gene function by double-stranded RNA in early mouse development. Nat. Cell. Biol. 2 (2000) 70-75
21. Hough S.R., Wiederholt K.A., Burrier A.C., Woolf T.M., and Taylor M.F. Why RNAi makes sense. Nat. Biotechnol. 21 (2003) 731-732
22. Lewis D.L., Hagstrom J.E., Loomis A.G., Wolff J.A., and Herweijer H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat. Genet. 32 (2002) 107-108
23. Tijsterman M., Ketting R.F., and Plasterk R.H. The genetics of RNA silencing. Annu. Rev. Genet. 36 (2002) 489-519
24. Zamore P.D., Tuschl T., Sharp P.A., and Bartel D.P. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101 (2000) 25-33
25. Bernstein E., Caudy A.A., Hammond S.M., and Hannon G.J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409 (2001) 363-366
26. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
27. Elbashir S.M., Lendeckel W., and Tuschl T. RNA interference is mediated by 21-and 22-nucleotide RNAs. Genes Dev. 15 (2001) 188-200
28. Elbashir S.M., Martinez J., Patkaniowska A., Lendeckel W., and Tuschl T. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20 (2001) 6877-6888
29. Tijsterman M., and Plasterk R.H.A. Dicer at RISC: the mechanism of RNAi. Cell 117 (2004) 1-3
30. Caudy A.A., Ketting R.F., Hammond S.M., Denli A.M., Bathoorn A.M., Tops B.B., Silva J.M., Myers M.M., Hannon G.J., and Plasterk R.H. A micrococcal nuclease homologue in RNAi effector complexes. Nature 425 (2003) 411-414
31. Doench J.G., Petersen C.P., and Sharp P.A. SiRNAs can function as MIRNAS. Genes Dev. 17 (2003) 438-442
32. Lee R.C., Feinbaum R.L., and Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 (1993) 843-854
33. Hutvagner G., McLachlan J., Pasquinelli A.E., Balint E., Tuschl T., and Zamore P.D. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293 (2001) 834-838
34. Song E.W. RNA interference: from biology to therapeutics. 1st ed (2005), Higher Education Press, Beijing 57-58
35. Tsutsumi T., Hirayama F., Uekama K., and Arima H. Evaluation of polyamidoamine dendrimer/α-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA). J. Control. Release 119 (2007) 349-359
36. Jackson A.L., Bartz S.R., Schelter J., Kobayashi S.V., Burchard J., Mao M., Li B., Cavet G., and Linsley P.S. Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21 (2003) 635-637
37. Dave R.S., and Pomerantz R.J. RNA interference: on the road to an alternate therapeutic strategy. Rev. Med. Virol. 13 (2003) 373-385
38. Schiffelers R.M., Woodle M.C., and Scaria P. Pharmaceutical prospects for RNA interference. Pharm. Res. 21 (2004) 1-7
39. Zimmermann T.S., Lee A.C.H., Akinc A., Bramlage B., Bumcrot D., Fedoruk M.N., Harborth J., Heyes J.A., Jeffs L.B., John M., Judge A.D., Lam K., McClintock K., Nechev L.V., Palmer L.R., Racie T., Rohl I., Seiffert S., Shanmugam S., Sood V., Soutschek J., Toudjarska I., Wheat A.J., Yaworski E., Zedalis W., Koteliansky V., Manoharan M., Vornlocher H.P., and MacLachlan I. RNAi-mediated gene silencing in non-human primates. Nature 441 (2006) 111-114
40. Foged C., Nielsen H.M., and Frokjaer S. Liposomes for phospholipase A2 triggered siRNA release: Preparation and in vitro test. Int. J. Pharm. 331 (2007) 160-166
41. Kim T.H., Kim S.I., Akaike T., and Cho C.S. Synergistic effect of poly (ethylenimine) on the transfection efficiency of galactosylated chitosan/DNA complexes. J. Control. Release 105 (2005) 354-366
42. Katas H., and Alpar H.O. Development and characterisation of chitosan nanoparticles for siRNA delivery. J. Control. Release 115 (2006) 216-225
43. Spagnou S., Miller A.D., and Keller M. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Biochemistry 43 (2004) 13348-13356
44. Malone R.W., Felgner P.L., and Verma I.M. Cationic liposome-mediated RNA transfection. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 6077-6081
45. Dalby B., Cates S., Harris A., Ohki E.C., Tilkins M.L., Price P.J., and Ciccarone V.C. Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods 33 (2004) 95-103
46. Lorenz C., Hadwiger P., John M., Vornlocher H.P., and Unverzagt C. Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells. Bioorg. Med. Chem. Lett. 14 (2004) 4975-4977
47. Khoury M., Louis-Plence P., Escriou V., Noel D., Largeau C., Cantos C., Scherman D., Jorgensen C., and Apparailly F. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor α in experimental arthritis. Arthritis Rheum. 54 (2006) 1867-1877
48. Leng Q., Scaria P., Zhu J., Ambulos N., Campbell P., and Mixson A.J. Highly branched HK peptides are effective carriers of siRNA. J. Genet. Med. 7 (2005) 977-986
49. Flynn M.A., Casey D.G., Todryk S.M., and Mahon B.P. Efficient delivery of small interfering RNA for inhibition of IL-12p40 expression in vivo. J. Inflam. 1 (2004) 1-4
50. Sioud M., and Søensen D.R. Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem. Biophys. Res. Commun. 312 (2003) 1220-1225
51. Sorensen D.R., Leirdal M., and Sioud M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J. Mol. Biol. 327 (2003) 761-766
52. Ma Z., Li J., He F., Wilson A., Pitt B., and Li S. Cationic lipids enhance siRNA-mediated interferon response in mice. Biochem. Biophys. Res. Commun. 330 (2005) 755-759
53. Miyawaki-Shimizu K., Predescu D., Shimizu J., Broman M., Predescu S., and Malik A.B. siRNA-induced caveolin-1 knockdown in mice increases lung vascular permeability via the junctional pathway. Am. J. Physiol., Lung Cell Mol. Physiol. 290 (2006) L405-L413
54. Landen Jr. C.N., Chavez-Reyes A., Bucana C., Schmandt R., Deavers M.T., Lopez-Berestein G., and Sood A.K. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res. 65 (2005) 6910-6918
55. Sato A., Takagi M., Shimamoto A., Kawakami S., and Hashid M. Small interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in mice. Biomaterials 28 (2007) 1434-1442
56. Barreau C., Dutertre S., Pailiard L., and Osborne H.B. Liposome-mediated RNA transfection should be used with caution. RNA 12 (2006) 1790-1793
57. Bai X.M., Zhou D.P., Brown J.R., Crawford B.E., Hennet T., and Esko J.D. Biosynthesis of the linkage region of glycosaminoglycans: cloning and activity of galactosyltransferase II, the sixth member of the β 1,3-galatosyltransferase family (β 3GalT6). J. Biol. Chem. 276 (2001) 48189-48195
58. Troussard A.A., Mawji N.M., Ong C., Mui A., St.-Arnaud R., and Dedhar S. Conditional knock-out of integrin-linked kinase (ILK) demonstrates an essential role in PKB/Akt activation. J. Biol. Chem. 278 (2003) 22374-22378
59. Leu Y.W., Rahmatpanah F., Shi H.D., Wei S.H., Liu J.C., Yan P.S., and Hui-Ming Huang T. Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation. Cancer Res. 63 (2003) 6110-6115
60. Leirdal M., and Sioud M. Gene silencing in mammalian cells by preformed small RNA duplexes. Biochem. Biophys. Res. Commun. 295 (2002) 744-748
61. Richards Grayson A.C., Ma J., and Putnam D. Kinetic and efficacy analysis of RNA interference in stably and transiently expressing cell lines. Mol. Pharmaceutics 3 (2006) 601-613
62. Kip1. J. Biol. Chem. 278 (2003) 29619-29625
63. Gilmore I.R., Fox S.P., Hollins A.J., and Akhtar S. Delivery strategies for siRNA-mediated gene silencing. Curr. Drug Deliv. 3 (2006) 147-155
64. Van de Wetering P., Schuurmans-Nieuwenbroek N.M., Hennink W.E., and Storm G. Comparative transfection studies of human ovarian carcinoma cells in vitro, ex vivo and in vivo with poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes. J. Gene Med. 1 (1999) 156-165
65. Kabanov V.A., and Kabanov A.V. Interpolyelectrolyte and block ionomer complexes for gene delivery: physico-chemical aspects. Adv. Drug Deliv. Rev. 30 (1998) 49-60
66. Wolfert M.A., Schaht E.H., Tonceva V., Ulbrich K., Nazarova O., and Seymour L.W. Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymers. Hum. Gene Ther. 7 (1996) 2123-2133
67. Katayose S., and Kataoka K. Remarkable increase in nuclease resistance of plasmid DNA through supramolecular assembly with poly(ethylene glycol)-poly(l-lysine) block copolymer. J. Pharm. Sci. 87 (1998) 160-163
68. Wang L., Kristensen J., and Ruffner D.E. Delivery of antisense oligonucleotides using HPMA polymer: synthesis of A thiol polymer and its conjugation to water-soluble molecules. Bioconjug. Chem. 9 (1998) 749-757
69. Jensen K.D., Kopeckova P., Bridge J.H.B., and Kopecek J. The cytoplasmic escape and nuclear accumulation of endocytosed and microinjected HPMA copolymers and a basic kinetic study in Hep G2 cells. AAPS PharmSci 3 (2001) (Article 32)
70. Subr V., Konak C., Laga R., and Ulbrich K. Coating of DNA/poly(l-lysine) complexes by covalent attachment of poly[N-(2-hydroxypropyl)methacrylamide]. Biomacromolecules 7 (2006) 122-130
71. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., and Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7297-7301
72. Behr J.P. The proton sponge: a trick to enter cells the viruses did not exploit. Chimia 51 (1997) 34-36
73. Ferrari S., Pettenazzo A., Garbati N., Zacchello F., Behr J.P., and Scarpa M. Polyethylenimine shows properties of interest for cystic fibrosis gene therapy. Biochim. Biophys. Acta 1447 (1999) 219-225
74. Godbey W.T., Barry M.A., Saggau P., Wu K.K., and Mikos A.G. Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery. J. Biomed. Mater. Res. 51 (2000) 321-328
75. Ferrari S., Moro E., Pettenazzo A., Behr J.P., Zacchello F., and Scarpa M. Exgen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo. Gene Ther. 4 (1997) 1100-1106
76. Goula D., Remy J.S., Erbacher P., Wasowicz M., Levi G., Abdallah B., and Demeneix B.A. size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther. 5 (1998) 712-717
77. Demeneix B., Behr J., Boussif O., Zanta M.A., Abdallah B., and Remy J. Gene transfer with lipospermines and polyethylenimines. Adv. Drug Deliv. Rev. 30 (1998) 85-95
78. Kren B.T., Parashar B., Bandyopadhyay P., Chowdhury N.R., Chowdhury J.R., and Steer C.J. Correction of the UDP-glucuronosyltransferase gene defect in the gunn rat model of Crigler-Najjar syndrome type I with a chimeric oligonucleotide. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 10349-10354
79. Ogris M., Steinlein P., Kursa M., Mechtler K., Kircheis R., and Wagner E. The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther. 5 (1998) 1425-1433
80. Kircheis R., Kichler A., Wallner G., Kursa M., Ogris M., Felzmann T., Buchberger M., and Wagner E. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther. 4 (1997) 409-418
81. Kircheis R., Schuller S., Brunner S., Ogris M., Heider K.H., Zauner W., and Wagner E. Polycation-based DNA complexes tumor-targeted gene delivery in vivo. J. Gene Med. 1 (1999) 111-120
82. Ogris M., Brunner S., Schuller S., Kiacheis R., and Wagner E. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 6 (1999) 595-605
83. Hassani Z., Lemkine G.F., Erbacher P., Palmier K., Alfama G., Giovannangeli C., Behr J.P., and Demeneix B.A. lipid mediated siRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels. J. Gene Med. 7 (2005) 198-207
84. Niola F., Evangelisti C., Campagnolo L., Massalini S., Bue M.C., Mangiola A., Masotti A., Maira G., Farace M.G., and Ciafre S.A. A plasmid-encoded VEGF siRNA reduces glioblastoma angiogenesis and its combination with interleukin-4 blocks tumor growth in a xenograft mouse model. Cancer Biol. Ther. 5 (2006) 174-179
85. Thomas M., Lu J.J., Ge Q., Zhang C., Chen J., and Klibanov A.M. Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 5679-5684
86. Werth S., Urban-Klein B., Dai L., Höbel S., Grzelinski M., Bakowsky U., Czubayko F., and Aigner A. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes. J. Control. Release 112 (2006) 257-270
87. Patnaik S., Aggarwal A., Nimesh S., Goel A., Ganguli M., Saini N., Singh Y., and Gupta K.C. PEI-alginate nanocomposites as efficient in vitro gene transfection agents. J. Control. Release 114 (2006) 398-409
88. Mao S., Neu M., Germershaus O., Merkel O., Sitterberg J., Bakowsky U., and Kissel T. Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/siRNA polyplexes. Bioconjug. Chem. 17 (2006) 1209-1218
89. Ge Q., Filip L., Bai A., Nguyen T., Eisen H.N., and Chen J. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 8676-8681
90. Urban-Klein B., Werth S., Abuharbeid S., and Czubayko F. A. Aigner. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther. 12 (2005) 461-466
91. Lee M.K., Chun S.K., Choi W.J., Kim J.K., Choi S.H., Kim A., Oungbho K., Park J.S., Ahn W.S., and Kim C.K. The use of chitosan as a condensing agent to enhance emulsion-mediated gene transfer. Biomaterials 26 (2005) 2147-2156
92. Shu X.Z., and Zhu K.J. The influence of multivalent phosphate structure on the properties of ionically cross-linked chitosan films for controlled drug release. Eur. J. Pharm. Biopharm. 54 (2002) 235-243
93. Mao H.Q., Roy K., Truong-Le V.L., Janes K.A., Lin K.Y., Wang Y., August J.T., and Leong K.W. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J. Control. Release 70 (2001) 399-421
94. Kiang T., Wen J., and Lim H.W. K.W. Leong. The effect of the degree of chitosan deacetylation on the efficiency of gene transfection. Biomaterials 25 (2004) 5293-5301
95. Liu W., Sun S., Cao Z., Zhang X., Yao K., Lu W.W., and Luk K.D. An investigation on the physicochemical properties of chitosan/DNA polyelectrolyte complexes. Biomaterials 26 (2005) 2705-2711
96. Liua X., Howarda K.A., Donga M., Andersena M.O., Rahbeka U.L., Johnsenc M.G., Hansenc O.C., Besenbachera F., and Kjems J. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials 28 (2007) 1280-1288
97. Howard K.A., Rahbek U.L., Liu X.D., Damgaard C.K., Glud S.Z., Andersen M.O., Hovgaard M.B., Schmitz A., Nyengaard J.R., Besenbacher F., and Kjems J. RNA interference in vitro and in vivo using a chitosan/siRNA nanoparticle system. Mol. Ther. 14 (2006) 476-484
98. Moriguchi R., Kogure K., Akita H., Futaki S., Miyagishi M., Taira K., and Harashima H. A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids. Int. J. Pharm. 301 (2005) 277-285
99. Choi Y.H., Liu F., Kim J.S., Choi Y.K., Park J.S., and Kim S.W. Polyethylene glycol-grafted poly-L-lysine as polymeric gene carrier. J. Control. Release 54 (1998) 39-48
100. Oupicky D., Konak C., Ulbrich K., Wolfert M.A., and Seymour L.W. DNA delivery systems based on complexes of DNA with synthetic polycations and their copolymers. J. Control. Release 65 (2000) 149-171
101. Harada-Shiba M., Yamauchi K., Harada A., Takamisawa I., Shimokado K., and Kataoka K. Polyion complex micelles as vectors in gene therapy-pharmacokinetics and in vivo gene transfer. Gene Ther. 9 (2002) 407-414
102. Itaka K., Kanayama N., Nishiyama N., Jang W.D., Yamasaki Y., Nakamura K., Kawaguchi H., and Kataoka K. Supramolecular nanocarrier of siRNA from PEG-based block catiomer carrying diamine side chain with distinctive pKa directed to enhance intracellular gene silencing. J. Am. Chem. Soc. 126 (2004) 13612-13613
103. Matsui K., Horiuchi S., Sando S., Sera T., and Aoyama Y. RNAi silencing of exogenous and endogenous reporter genes using a macrocyclic octaamine as a "compact" siRNA carrier. Studies on the nonsilenced residual activity. Bioconjug. Chem. 17 (2006) 132-138
104. Lemaitre M., Bayard B., and Lebleu B. Specific antiviral activity of poly(l-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 648-652
105. Derossi D., Joliot A.H., Chassaing G., and Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269 (1994) 10444-10450
106. Lindsay M.A. Peptide-mediated cell delivery: application in protein target validation. Curr. Opin. Pharmacol. 2 (2002) 587-594
107. Turner J.J., Jones S., Fabani M.M., Ivanova G., Arzumanov A.A., and Gait M.J. RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA. Blood Cells Mol. Diseases 38 (2007) 1-7
108. O. Mykhaylyk, D. Vlaskou, N. Tresilwised, P. Pithayanukul, W. Möller, C. Plank, Magnetic nanoparticle formulations for DNA and siRNA delivery, J. Magn. Magn. Mater. (in press).
109. Kam N.W., Liu Z., and Dai H. Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. J. Am. Chem. Soc. 127 (2005) 12492-12493